S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion — Stella

Home/Transfusion Related Complication/

View on ClinicalTrials.gov

Recruiting

Back to Transfusion Related Complication trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

University Hospitals Cleveland Medical Center, Cleveland, Ohio

Key details

Phase

Early testing

Sponsor

James Reynolds

Collaborators

Case Western Reserve University, National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~35 participants

Started

July 2019

Primary completion

February 2028

Age range

18 Years – 35 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.